Multiple Healthcare-Themed Funds Achieve "Performance Breakthrough"

Unlike in the first half of this year, several healthcare-themed funds shifted from "trailing" to "leading" in the third quarter, achieving a "performance breakthrough." As of the time of this report, multiple healthcare-themed funds, including Yongying Hong Kong Stock Connect Healthcare ETF, Zhongou Medicine & Biotech Mixed Fund (Initiation), and Southern Hong Kong Stock Pharmaceutical Industry Mixed Fund (Initiation) (QDII), ranked high in net asset value growth rates. Looking ahead, the fund manager of Southern Hong Kong Stock Pharmaceutical Industry Mixed Fund (Initiation) (QDII) said they remain optimistic about the medium- to long-term opportunities in innovative drugs and the innovative drug industry chain. The portfolio will continue to use bottom-up research to identify companies with clear industry trends, fundamentals that can be verified, and valuations that still offer reasonable return potential, and will dynamically rebalance among innovative drugs, CXO, and emerging technology directions. (Securities Daily)